Sagitta Asset Management is preparing to launch a global healthcare fund for institutional and high net worth investors.

The fund will invest in pharmaceuticals, biotechnology and medical technology company stocks. It will make minimum investments of $50,000 (€54,147) and will be an absolute return vehicle, as there are no benchmarks suitable for a global healthcare investment fund. The fund will be domiciled in Dublin and charge an annual management fee of 1.25%.